Science
Mechanism of Action
This advanced peptide functions by acting as a signaling molecule within the skin, prompting the activation of the body’s endogenous repair pathways. It is synthesized as a recombinant single-chain fusion peptide, meticulously produced via fermentation in E. coli, with its genetic structure derived from the precise fusion of r-Bovine Octapeptide-1, Tripeptide-49, Oligopeptide-91, and Dipeptide-19.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
No specific safety assessments from major regulatory bodies such as CIR, SCCS, or FDA are publicly available for TRIPEPTIDE-49 OLIGOPEPTIDE-91 DIPEPTIDE-19 R-BOVINE OCTAPEPTIDE-1, including defined maximum concentration levels for safe use. It is often identified as a 'new ingredient' or one with 'information pending review' in cosmetic databases, indicating that comprehensive safety data is still being gathered or is not yet public.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While theorized to stimulate skin regeneration and strengthen skin structure through its peptide signaling mechanism, the absence of comprehensive clinical studies, detailed safety assessments, and specific skin compatibility data means its full efficacy and safety profile currently lack precision for a definitive Moumoujus recommendation.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources